Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac

Terapevticheskii Arkhiv

Volumn 79, Issue 5, 2007, Pages 35-40

  Kudaeva, F M ^a   Eliseev, M S ^a   Barskova, V G ^a   Nasonova, V A ^a  

^a NONE

Author keywords

Gout; Inflammation; Nimesulide; Pain; Sodium diclofenac

Indexed keywords

DICLOFENAC; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONAMIDE;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GOUT; HOSPITALIZATION; HUMAN; MALE; PAIN; POWDER; TABLET; TIME; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, GOUTY; DICLOFENAC; FEMALE; HUMANS; MALE; PAIN; POWDERS; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TABLETS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34547491168     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Russian source
2. Cheng T. T., Lai H. M., Chiu C. K., Chem Y. C. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis. Clin. Ther. 2004; 26 (3): 399-406.
3. Schumacher H. R., Boice J. A., Daikh D. I. et al. Randomised double blind trial of etoricoxib and Indometacin of acute gouty arthritis. Br. Med. J. 2002; 324 (7352): 1488-1492.
4. Zhang W., Doherty M., Bardin T. et al. EULAR evidence based recommendation for gout - Part II management: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 2006. doi:10.1136/ard.2006.055269.
5. Russian source
6. Russian source
7. Bennett A. Nimesulide, a well established cyclooxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory diseases. In: Vein J. R., Botting R. M., eds. Therapeutic roles of selective COX-2 inhibitors. William Harvey Press; 524-540.
8. Cannon G. W., Caldwell J. R., Holt P. et al. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium. Arthr. and Rheum. 2000; 43: 978-987.
9. Morrison B. W., Christensen S., Yuan W. et al. Analgesic efficacy of the inhibitor of cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial. Clin. Ther. 1999; 21: 943-953.
10. Bennett A., Berti F., Ferreira S. H., eds. Nimesulide: a multi-factorial therapeutic approach to the inflammatory process? A 7-year clinical experience. Drugs 1993; 46 (suppl. 1): 1-283.
11. Pulkinnen M. O. The effect of nimesulide on intrauterine pressure in dysmenorrhoeic women. Drugs Exp. Res. 1984; 10: 599-606.
12. Pulkinnen M. O. Nimesulide in dysmenorrhoea. Drugs 1993; 46 (suppl. 1): 129-133.
13. Wallace S. L., Robinson H., Masi A. T. et al. Preliminary criteria for the classification of the acute arthritis of gout. Arthr. and Rheum. 1977; 20: 895-900.
14. Pouliot M., James M. J., McColl S. R. et al. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998; 91 (5): 1769-1776.
15. Marzo A., Dal Bo L., Verga F. et al. Pharmacokinetics of diclofenac after oral administration of its potassium salt in sachet and tablet formulations. Arznetimittel-Forschung 2000; 59 (1): 43-47.
16. Lotsch J., Kettenman B., Renner B. et al. Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model. Pharmacol. Res. 2000; 17 (1): 77-84.
17. Bernareggi A. Pharmacokinetics of nimesulide. Clin. Pharm. 1998; 35 (4): 247-274.
18. Terhaag B., Gramatte T., Hrdlcka P. et al. The influence of food on the absorbtion of diclofenac as a pure substance. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29 (10): 418-421.
19. Gupta S. K., Velpandian T., Mathur P., Sengupta S. Comparative analgesic activity of nimesulide and diclofenac by intramuscular route: correlation with pharmacokinetics profile of nimesulide. Pharmacology 1998; 56 (3): 137-143.
20. Amodeo C., De Marco M., Gambarini G. A clinical study of the efficacy and tolerance of nimesulide compared to flurbiprofen and sodium diclofenac in the prevention and treatment of postoperative pain and inflammatory symptoms in densitry. Minerva Stomatol. 1992; 41 (12): 567-576.
21. Di Giovine F. S., Malawista S. E., Thornton E., Duff G. W. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J. Clin. Invest. 1991; 87 (4): 1375-1381.
22. Bunczak-Reeh M. A., Hargreaves K. M. Effect of inflammation on the delivery of drugs to dental pulp. J. Endodonitics 1998; 24: 822-824.